Not finding it? Sign in to also search OpenAlex live.
-
208P Clinical importance of residual axillary disease following neoadjuvant systemic therapy as an indicator for adjuvant systemic therapy in HER2+ and triple-negative breast cancer2025 ESMO Open article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Eva L. Claassens, Linetta B. Koppert, Carmen C. van der Pol, Ernest J. T. Luiten, Thiemo J. A. van Nijnatten, Janine M. Simons, +1 more
0citations -
Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial2020 International Journal of Radiation Oncology*Biology*Physics article Medicine Endometrial and Cervical Cancer Treatments Open access
Cathalijne Post, Stephanie M. de Boer, Melanie E. B. Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, +24 more
47citations -
Switching PD‐1 to BRAF + MEK inhibition improves recurrence‐free survival in patients receiving a second course of adjuvant melanoma therapy2025 Journal of the European Academy of Dermatology and Venereology article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways Open access
Katharina Schumann, Kai Christian Klespe, Cornelia Mauch, Carmen Loquai, Ulrike Schultheis, Sevil Börger, +20 more
1citations -
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy2020 International Journal of Gynecological Cancer article Medicine Endometrial and Cervical Cancer Treatments Open access
Anne Sophie V M van den Heerik, Nanda Horeweg, Stephanie M. de Boer, Tjalling Bosse, Carien L. Creutzberg
198citations -
Impact of less invasive axillary staging procedures after neoadjuvant systemic therapy on adjuvant systemic therapy indications in HER2-positive and triple-negative breast cancer2026 European Journal of Surgical Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Eva L. Claassens, Linetta B. Koppert, Carmen C. van der Pol, Ernest J. T. Luiten, Thiemo J. A. van Nijnatten, Agnes Jager, +18 more
0citations -
Adjuvant Transgingival Therapy with Visible Light Plus Water-Filtered Infrared-A (VIS + wIRA) in Periodontal Therapy—A Randomized, Controlled, Stratified, Double-Blinded Clinical Trial
Stefanie Anna Peikert, Anil Fischer, Anne Kruse, Ali Al‐Ahmad, Johan Peter Woelber, Kirstin Vach, +2 more
2citations -
Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma: A Propensity-Matched Outcome Analysis2023 Cancers article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways Open access
Melissa Melanie de Meza, Willeke A.M. Blokx, Johannes J. Bonenkamp, Christian U. Blank, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, +14 more
16citations -
Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial2023 EClinicalMedicine article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Vivianne C. G. Tjan‐Heijnen, Senna W. M. Lammers, Sandra M. E. Geurts, Ingeborg J. H. Vriens, Astrid C P Swinkels, Carolien H. Smorenburg, +8 more
16citations -
The effects of tumor resection and adjuvant therapy on the peripheral blood immune cell profile in patients with colon carcinoma2020 Cancer Immunology Immunotherapy article Medicine Cancer Immunotherapy and Biomarkers Open access
Daniëlle Krijgsman, Natasja L. De Vries, Morten Nørgaard Andersen, Anni Skovbo, Rob A.�E.�M. Tollenaar, Esther Bastiaannet, +2 more
15citations -
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial
Irene L. M. Reijers, Alexander Maxwell Menzies, Alexander C. J. van Akkooi, Judith M. Versluis, N.M.J. Van Den Heuvel, Robyn P.M. Saw, +31 more
378citations -
Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor–Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial
Sonja B. Vliek, Iris Noordhoek, Elma Meershoek‐Klein Kranenbarg, Annelot G.J. van Rossum, Vincent Olaf Dezentjé, Agnes Jager, +12 more
21citations -
Prevalence, clinical and molecular characteristics of early stage EGFR-mutated lung cancer in a real-life West-European cohort: Implications for adjuvant therapy
Liesbeth M. Hondelink, Sophie M. Ernst, Peggy N. Atmodimedjo, Danielle B. Cohen, Janina L Wolf, Anne‐Marie C. Dingemans, +2 more
33citations -
Side-effects in women treated with adjuvant endocrine therapy for breast cancer2025 The Breast article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Roxanne Gal, Anne Maria May, Marilot C. T. Batenburg, Femke van der Leij, Rhodé M. Bijlsma, Helena Marieke Verkooijen, +5 more
12citations -
Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials2020 Critical Reviews in Oncology/Hematology article Medicine Cholangiocarcinoma and Gallbladder Cancer Studies Open access
Ali Belkouz, Johanna W. Wilmink, Nadia Haj Mohammad, Jeroen Hagendoorn, Judith de Vos‐Geelen, C.H.C. Dejong, +6 more
18citations -
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy2020 Journal of Clinical Oncology article Medicine Endometrial and Cervical Cancer Treatments Open access cited by 1 patent
Alicia León‐Castillo, Stephanie M. de Boer, Melanie E. B. Powell, Linda Mileshkin, Helen J MacKay, Alexandra F. Leary, +16 more
877citations -
133O Extended adjuvant aromatase inhibition after sequential endocrine therapy: Final results of the phase III DATA trial2022 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
V.C.G. Tjan-Heijnen, S.W.M. Lammers, Sandra M. E. Geurts, Ingeborg J. H. Vriens, Astrid C P Swinkels, Carolien H. Smorenburg, +8 more
5citations -
Axillary staging and adjuvant systemic therapy indications for residual HER2-positive and triple-negative breast cancer2025 European Journal of Surgical Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Eva L. Claassens, L. B. Koppert, Carmen C. van der Pol, Ernest J. T. Luiten, Thiemo J. A. van Nijnatten, Marjolein L. Smidt, +1 more
0citations -
Early Cessation of Adjuvant Anti‐ PD ‐1 Therapy in Stage III and IV Melanoma2026 International Journal of Cancer article Medicine Cutaneous Melanoma Detection and Management Open access
Manja Bloem, Melissa Melanie de Meza, C D M Boreel, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Christian U. Blank, +15 more
0citations -
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy138citations
-
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy2022 Zurich Open Repository and Archive (University of Zurich) article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Vincent M. T. de Jong, Yuwei Wang, Natalie D. ter Hoeve, Mark Opdam, Nikolas Stathonikos, Katarzyna Jóźwiak, +25 more
100citations